Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 130 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Crizanlizumab (formerly SelG1) for Sickle Cell Disease	Crizanlizumab (SEG101; Adakveo)	Sickle cell anaemia	Haematology	2017	View \| Download
Clostridium botulinum Type A toxin (Dysport) for Spasmodic torticollis	Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607)	Spasmodic torticollis	Musculoskeletal System , Neurology	2017	View \| Download
Clostridium botulinum neurotoxin A (Xeomin) for lower limb spasticity due to cerebral palsy – first line	Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607)	Lower limb spasticity	Musculoskeletal System , Neurology	2017	View \| Download
Cethrin for traumatic spinal cord injury	Cethrin (BA 210; VX-210)	Spinal cord injury	Musculoskeletal System	2017	View \| Download
Certolizumab pegol (Cimzia) for chronic plaque psoriasis in adults	Certolizumab (CDP-870; Cimzia; certolizumab pegol)	Plaque psoriasis	Dermatology	2017	View \| Download
Cenicriviroc for non-alcoholic steatohepatitis (NASH)	Cenicriviroc (TAK-652; Cenicriviroc Mesylate)	Non-alcoholic steatohepatitis (NASH)	Hepatology	2017	View \| Download
Cemiplimab for advanced cutaneous squamous cell	Cemiplimab (Libtayo; REGN2810)	Squamous cell carcinoma (SCC)	Skin Cancer	2017	View \| Download
Cannabidiol in a pharmaceutical formulation (Epidiolex; GWP42003-P) for Lennox-Gastaut syndrome in children and adults	Cannabidiol (BRCX-014; Epidiolex; GW42003; GWP42003; GWP-42003; PG-DN-20WS)	Lennox-Gastaut syndrome	Neurology	2017	View \| Download
Cannabidiol (Epidiolex) for Tuberous Sclerosis Complex - add-on therapy	Cannabidiol (BRCX-014; Epidiolex; GW42003; GWP42003; GWP-42003; PG-DN-20WS)	Tuberous sclerosis	Genetic Disorders	2017	View \| Download
Canakinumab (ILARIS) for Cardiovascular risk reduction – Add on therapy	Canakinumab (Ilaris; ACZ885)	Cardiovascular disease (CVD)	Cardiovascular System	2017	View \| Download